Solmucol Bronchoprotect 50 mg

Solmucol Bronchoprotect 50 mg is a medicine authorised by Swissmedic under authorisation number 67822. The authorisation holder is IBSA Institut Biochimique SA. The medicinal product code is Bacterial and yeast preparations and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 06 January 2022 and the authorisation is valid without a time limit. ATC code R07AX places the medicine in the group Other respiratory system products.

  • Dispensing category D
  • Authorisation number 67822
  • ATC R07AX
  • Bacterial and yeast preparations
Authorisation data
Authorisation number67822
NameSolmucol Bronchoprotect 50 mg
Full nameSolmucol Bronchoprotect 50 mg, compresse sublinguali
Authorisation holderIBSA Institut Biochimique SA
Medicinal product codeBacterial and yeast preparations
Dispensing categoryD · No prescription, with advice
ATC codeR07AX
First authorisation06 January 2022
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Solmucol Bronchoprotect 50 mg, compresse sublingualiD06 January 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Tablette(n)R07AX03.05.0.D

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Solmucol Bronchoprotect 50 mg authorised in Switzerland?

Yes. Solmucol Bronchoprotect 50 mg is authorised by Swissmedic under authorisation number 67822, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Solmucol Bronchoprotect 50 mg have?

Solmucol Bronchoprotect 50 mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.

Who is the authorisation holder of Solmucol Bronchoprotect 50 mg?

The authorisation holder is IBSA Institut Biochimique SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com